Search For

Targeting gut microbiota to overcome immunotherapy resistance in hepatocellular carcinoma: from mechanisms to clinical practice

An activated CD8⁺ T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Metabolic reprogramming and the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic targeting

Molecular characteristics of fatty acid metabolic reprogramming in hepatocellular carcinoma and their implications for immunotherapy

Rewiring the tumor microenvironment in hepatocellular carcinoma: mechanism-driven integration of immunotherapy and locoregional strategies

Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in hepatocellular carcinoma patients receiving TACE plus immunotherapy

Immune microenvironment and immunotherapy strategies in MAFLD-related hepatocellular carcinoma

Influence of the gut microbiota on the response to immunotherapy in hepatocellular carcinoma

Radioembolization for hepatocellular carcinoma: updated strategies and evolving clinical applications

Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article